United BioPharma To Build $33.2 Million Plant In Taiwan
This article was originally published in PharmAsia News
Executive Summary
United BioPharma said it would build a $33.2 million antibody-production plant a home in Taiwan, expected to be operational by the end of 2016 and making 100 kilograms a year.